Application Information

This drug has been submitted to the FDA under the reference 202171/001.

Names and composition

"LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE" is the commercial name of a drug composed of LAMIVUDINE and TENOFOVIR DISOPROXIL FUMARATE and NEVIRAPINE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
202171/001 LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE TABLET/ ORAL 300MG and 300MG and 200MG
204505/001 LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE TABLET/ ORAL 300MG and 300MG and 200MG
205355/001 LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE TABLET/ ORAL 300MG and 300MG and 200MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
202171/001 LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE TABLET/ ORAL 300MG and 300MG and 200MG
204505/001 LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE TABLET/ ORAL 300MG and 300MG and 200MG
205355/001 LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE TABLET/ ORAL 300MG and 300MG and 200MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved